chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Child received 3 vaccinations that day. 2 in her right thigh, and 1 vaccination in her left thigh. Site was cleaned well with alcohol pad prior to the injection. Injection sites approximately 1 1/2  to 2 inches apart. After injections done, bandaids placed. Child tolerated shots well. Mom reports to me that the next morning  she noticed that when her daughter woke up she had  redness and some swelling noted at the injection site. She called me (public health nurse), and I told her is probably having a localized reaction to the vaccines. Mom reports she really hasn't had this before with her other shots. I told her to put a covered ice pack over the site, as she will let you. If the swelling or redness gets any worse, or if she has a fever, she should seek medical treatment. Mom said that she understood and would continue to monitor the site. She took her in to an Urgent Care on Sunday 7/16/17 to seek medical treatment.  The Dr. there diagnosed that the injection site developed localized Cellulitis and opted to treat with Keflex bid X 10 days.   I called the Mom back this morning to get an update on her child and she then reported the above events.  Mom reports that her daughter is doing much better, swelling and redness are down, and she is up and playing.
Pt. states she woke up on 10/5/05 at 3:00 am with chills.  Left arm began to get very sore and erythmatous along with swelling.  Saw a physician on 10/6/06 at 11:00 am who diagnosed cellulitis and was put on Z-pak and ice packs, and was instructed to go to the ER if the site worsens.  There was some discrepancy on the site of each vaccine; pt. states she thought the influenza vaccine was given first in the right arm; and the pneumovax vaccine was given second in the left arm.  Also, pt. does not remember feeling the left arm being wiped with alcohol swab.
Stiff, painful swelling of entire left arm. Not tender to the touch but emitting a lot of heat. Started afternoon after injection and continuing for now with marked improvement.  Mild fever. Starting afternoon after injection and ending in afternoon the day after injection.
11:45 AM: PATIENT RECEIVED VACCINATIONS AFTER COMPLETING HER HEALTH ASSESSMENTS: FLU, HPV, AND TDAP WERE GIVEN.     11:48 AM: AFTER RECEIVING LAST VACCINE (TDAP) PT REPORTED FEELING LIGHTHEADED, DIZZY, AND NAUSEA. PT REPORTED SHE WAS FASTING, BUT MADE NO PRIOR MENTION OF BEING FASTING.    11:50 AM: VITALS TAKEN B/P: 77/48, P: 88, SAT: 100% & T: 97.9F. PT ALERT, DENIES ANY SOB, CHEST PAIN, OR DIFFICULTY SWALLOWING. PT WAS NOTED PALLOR WITH MILD DIAPHORESIS.    11:54 AM: VITAL TAKEN B/P: 89/66, P: 87, SAT: 100% & T: 98.7F. PT WAS IN A SITTING POSITION WITH LEGS ELEVATED.     11:57 AM: VITALS TAKEN B/P: 87/557, P: 86, SAT: 100% & T: 98.7F. PT WAS IN A SITTING POSITION WITH LEGS ELEVATED. PT WAS PROVIDED WITH SOME GATORADE. TOLERATED WELL. NO ACUTE DISTRESS NOTED.    12:03 PM: VITALS TAKEN B/P: 97/72, P: 78, SAT: 100% & T: 98.1F. PT WAS IN A SITTING POSITION WITH LEGS ELEVATED. NO ACUTE DISTRESS NOTED.    12:11 PM PATIENT STATES SHE WAS FEELING BETTER. PT NO LONGER REPORTS FEELING LIGHTHEADED OR DIZZY.    12:15 PM: VITALS TAKEN B/P: 92/65, P: 78, SAT: 100% & T: 98.1F. NO ACUTE DISTRESS NOTED.    12:20 PM: PT REPORTS FEELING BETER DENIES ANY SOB, CHEST PAIN, OR DIFFICULTY SWALLOWING. PT REMAINS IN OBSERVATION.     12:35 PM: PT VITALS TAKEN B/P: 98/66, P: 79, SAT: 100% & T: 98.1F. PT DISCHARGE AT THIS TIME WITH DISCHARGE INSTRUCTION AND REFERRAL TO PCP. PT ADVISED TO SEEK MEDICAL ATTENTION SHOULD SHE PRESENT WITH ANY HIVES, SOB, CHEST PAIN, ANGIOEDEMA, OR DIFFICULTY SWALLOWING. PT VERBALIZED UNDERSTANDING TO ALL DISCHARGE INSTRUCTION.
7/2021 started having severe joint pain, tenosynovitis, high sed rate, steroid repsonsive but symptoms worsened. Diagnosed with RA and started on Enbrel but not improving. 2/2/2022 presented to ER with acute worsening of polyarthrtis, diagnosed with multiple PE's on chest CT.
Pt developed fever, joint pain and muscles aches on 9/24/06.  continues with joint pain and aches, no fever, mild lymphadenopathy in neck.  No visible joint swelling.
one cm mass/bump subcutaneous identified below deltoid, reported at second vaccination on 4/22/2021.  patient reports reaction to skin in the shape of band-aid at site with potential reaction to band-aid in addition to 1 cm lump.  Mild outline of band-aid silhouette still noticeable. no rash, no red streaking, small lump in muscle at site. patient reports hx of "thin blood that does not clot easily". requested to not use band-aid this time. held site for a minute or two and no bleeding at site in deltoid for second shot, no lump this time.  appears that vaccine was provided below deltoid, laterally , just above the middle of the arm.  pt states lump is getting smaller but still there 22 days later.  because lump is still there, i that that the patient has not fully recovered.
Shortly after patient received the vaccine, she became faint and felt slightly nauseous. The patient was seated and was unresponsive for just a few seconds. She began to sweat and we applied an ice pack to her neck. Patient remained seated for 15 minutes and then we took her blood pressure. Blood pressure read 180/80. She was counseled to go the emergency room. Patient and husband said they were going to go home.  I then counseled patient to contact her doctor
reaction and thought that maybe it could have been a bad batch; reaction and thought that maybe it could have been a bad batch; anaphylactic shock; This spontaneous report was received from a consumer via Pfizer refers to a 4 year old female patient. The patient's concurrent conditions, medical history and concomitant therapies were not provided.  Approximately in 2009 (reported as "when she was 4 years old"), the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(manufacturer unknown) (dose, frequency, route, vaccination site and lot# were not provided), for prophylaxis.  Other suspect therapies included varicella virus vaccine live (oka/merck)(manufacturer unknown) (dose, frequency, route, vaccination site and lot# were not provided), for prophylaxis.  Approximately in 2009, the patient experienced anaphylactic shock, doctors were never sure of which ingredients may have caused the allergic reaction and thought that maybe it could have been a bad batch.  At the time of reporting, the outcome of anaphylactic shock was unknown.    The reporter considered anaphylactic shock to be related to varicella virus vaccine live (Oka/Merck)(Manufacturer unknown) and Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live(Manufacturer unknown).    Upon internal Review, anaphylactic shock was determined to be medically significant.
Vaccine was expired on 01-Apr-2022, refrigerated on 04-Apr-2022 and administered on 04-Apr-2022; Patient received expired Moderna COVID-19 Vccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna COVID-19 Vccine) and PRODUCT STORAGE ERROR (Vaccine was expired on 01-Apr-2022, refrigerated on 04-Apr-2022 and administered on 04-Apr-2022) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 04-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna COVID-19 Vccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 01-Apr-2022, refrigerated on 04-Apr-2022 and administered on 04-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna COVID-19 Vccine) and PRODUCT STORAGE ERROR (Vaccine was expired on 01-Apr-2022, refrigerated on 04-Apr-2022 and administered on 04-Apr-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was reported.  The vials were initially stored in refrigerator on 04-Apr-2022. The vial has not undergone temperature excursion. It was reported that the pharmacist thought that the expiry date of the vaccine was Jun-2022, however the vaccine expired on 01-Apr-2022. No treatment medication information was given.
Developed a rash with hives, pruitus, burning on whole body (worst areas: head, neck, arms, back, and posterior thighs) Displaying signs of Dermatographia.  Occurring all day worse at night and with hot temperatures/showers. Treated with prednisone 80mg taper, hydrocortisone cream, benadyrl initially, still taking allerga and singular.
PATIENT INDICATED HE DID NOT LIKE TO GET SHOTS.  AFTER THE ADMINISTRATION THE PATIENT WALKED TO WAITING AREA AND WITHIN 5 MINUTES HE HAS SLID OUT OF HIS CHAIR.  WHEN CHECKED THE PATIENT WAS VERY PALE AND SOMEWHAT NON RESPONSIVE.  I.E.  SLOW TO RESPOND.  HE WAS LAID IN FLOOR WITH FEET ELEVATED AS WELL AS 911 BEING NOTIFIED.  PARAMEDICS ARRIVED TO TREAT PATIENT AND WOUND UP HAVE TO TRANSPORT.
Working at my computer about two weeks after the shot and I suddenly had pressure and tinnitus in my left ear and hearing loss. Also nausea and dizziness in my head. The world started spinning, I lost all of my balance, I could not keep my eyes open to see and was hyper sensitive to noise and light. Wasn't sure if I was having a stroke or if it was something else. Pre shot my standing pulse for decades was always 56 to 60.  Post shot it usually 77.  It was about 85 at the time of the event.  I had no balance and the only way I could make it up the stairs was to grab things nearby and hold the rail and keep my eyes closed. I stumbled to our bed and called my wife to come check on me.  After about one hour I determined I had severe Vertigo. The entire world was spinning if I opened my eyes and I had no balance. Hyper sensitive to light and noise.  This lasted from 5.45 p.m. until 2 a.m. when I was finally able to open my eyes a bit and stumble to the kitchen to get a drink of water.  The next morning my head was still nauseas.  As I write this I do not feel right. I still have head related nausea and imbalance though it's not as severe as the day of the event.  I'm still alive and thankful for that but I feel awful.  I have not felt right or myself since having the shot and my standing pulse has gone from 56 to 77.   I have ongoing Vertigo though it's not as severe as the day I was completely debilitated.
Nurse in observation area stated to writer that BP decreased 20 minutes after immunization temporarily to 90's systolic and then when back up to 110 systolic . Heart rate was 103 consistently.  Individual complained of some dizziness writer was told.  Oxygen was 93% on room air. ER offered and individual declined. BP 110  systolic when individual left.
TOOK ONLY ONE DOSE; This spontaneous case (PVX2019-803) was received from a consumer on 03-Apr-2019. It describes a female consumer who "took only one dose", while being on oral Vivotif (one dose every other day) for typhoid fever prophylaxis.   Case report: The consumer took only one dose of Vivotif 1.5 weeks ago from the date of the report, after that she did not take the remaining doses.  Action taken with Vivotif was not applicable.   The clinical outcome of the event "took only one dose" was unknown.   Company's Comment: The causality of the event "took only one dose" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took only one dose" was considered as not applicable.
Approximately 10 minutes after administration, patient stated her chest felt heavy and she was feeling sweaty/hot. Approximately 5 minutes later, patient went into a absence seizure for roughly 5 minutes.
Patient given Moderna 0.5ml for booster dose, instead of 0.25ml. Multiple attempts made to contact patient unsuccessful.
Same day: headache, fatigue, localized arm tenderness Next day: headache, more fatigue, arm pain,  sharp pain in left arm pit, heart palpitations, spasm in left chest with pain that wrapped from sternum, under left breast to near shoulder.
Initial misuse report received from a healthcare professional on 12 February 2014. A patient had received only the DTaP/IPV component of PENTACEL. Vaccine underdose was administered to the patient. No adverse event was reported. List of documents held by sender: None.
Urticaria and angioedema with nausea/vomiting 48 hours after vaccination. Symptoms persisted responded to treatment but came back 6 days later and required further treatment with steroids.
This spontaneous report was received from a physician and a practice manager and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 19-JAN-2016, the patient was vaccinated with improperly stored dose of PNEUMOVAX 23 0.5 ml prefilled syringe (lot # L024132, expiration date: 21-JAN-2017; dose and route were not provided). The vaccine was exposed to following separate temperature excursions: first lasting for 56 hours, with the lowest recorded temperature of 33 degrees Fahrenheit (0.56 degrees Celsius), second lasting for 24 hours, with the lowest recorded temperature of 31 degrees Fahrenheit (-0.56 degrees Celsius). The vaccine was stored in a refrigerator. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Initial information has been received from a 65 year old female with allergies to grass and mold and no known drug allergies. Follow-up information was received from a registered nurse. On 13-JUN-2008 the patient was vaccinated  subcutaneously with a 0.65 ml dose of zoster vaccine live (Oka/Merck) (lot no. 659406/0298X). Concomitant therapy included (LOTREL) and (ZYRTEC). On 19-JUN-2008 (also reported as 16-JUN-2008) the patient experienced back pain, rash, burning sensation in the left posterior thorax and then shingles. On 21-JUN-2008 the patient went to the emergency room and her condition was diagnosed as shingles. The patient was started on (VALTREX) and (VICODIN). As of 25-JUN-2008, the patient was recovering from these events. On 27-JUN-2008 the patient was re-evaluated and diagnosed as post-herpetic neuralgia. The patient was treated with lidocaine (LIDODERM) patches and (LYRICA). Additional information is not expected.
Possible adverse reaction: severe right sided facial pain. ER visit 12/29/20.  Treatment: valcycolvir  for possible shingles, intranasal fentanyl at ER visit, oxycodone and gabapentin for pain
Information has been received from a mother concerning her 6 year old daughter born premature with no major health concerns who at the age of 2 was vaccinated with MMR. There were no concomitant medications. After receiving the vaccination, the child lost her words and was no longer trained to use the toilet. The patient reportedly lost all of her abilities. The mother reported that her daughter no longer knew who she was and was lethargic. The patient was diagnosed with autism shortly after receiving the vaccination. Follow up information received from a nurse practitioner concerning the 6 year old female patient who on 3/9/99 and on 8/24/04 was vaccinated with a first and second dose (lot # 648461/1306N) of MMR respectively. On 9/2/04 it was reported that within 24 hours the patient developed fever and cold symptoms. The reporter did not believe that the fever and cold symptoms were vaccine related. It was also noted that on 4/24/98, 6/26/98, 8/28/98, 9/7/99 the patient was vaccinated with diphtheria toxoid (+) pertussis vaccine (+) tetanus toxoid. On 4/24/98, 6/26/98, 8/28/98, and 9/7/99, the patient was vaccinated with poliovirus vaccine. On 3/3/04 and on 9/24/04 the patient received hepatitis B virus vaccine. On 9/13/96, 11/22/96, 1/17/97, and 1/23/98 the patient was vaccinated with HIB conjugate vaccine. Unspecified medical attention was sought. No product quality complaint involved. Upon internal review autism was considered to be other important medical event (OMIC). It was also reported that the patient's brother also had an adverse experience following vaccination with MMR. No further information is expected. Follow up 03/03/05: Patient has not recovered from the adverse events.
Same-day Pain and hardness at injection site followed by redness, then a splotchy rash at the injection site noticed the morning after the injection
REBOUND OF COVID SYMPTOMS 5 DAYS AFTER LAST DOSE OF PAXLOVID; This spontaneous report received from a patient concerned a 74 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 11-DEC-2021 13:00 for covid-19 prophylaxis. The batch number was not reported and has been requested. Age at time of vaccination 74 years old. No concomitant medications were reported.  On an unspecified date, the patient experienced rebound of covid symptoms 5 days after last dose of paxlovid. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from rebound of covid symptoms 5 days after last dose of paxlovid. This report was non-serious.
7/28/07 - bruise at injection site 7/2907 - 1/2 dollar red mark at injection site. 7/29/07 - evening tangerine red area at site - fever, headache, chills, warm to touch - 7/30 - 8 cm raised area at injection site.
Moderna vaccine was administered outside - reported by patient ? NO LOT NUMBER WERE SUPPLIED -------------------------------------------------------------------------------------------------------- G47.33 ADULT OBSTRUCTIVE SLEEP APNEA, SEVERE 3/24/2023 SLURRED SPEECH G62.9 PERIPHERAL NEUROPATHY 4/3/2023 SLURRED SPEECH
The night of the vaccination I began having fevers night sweats and radiating severe Right neck pain that radiates from my neck to my right ear up my R scalp and R front and to the top of my head causing severe chronic headaches constantly.  So far it has last for seven days with minimal relief and it is worse at night when I try to sleep causing me insomnia due to pain. Pressure in my head feels like my brain is about to explode and I feel it in my neck and back of my ear on the right side.
ALOPECIA AREATA UNIVERSALIS:  I have complete hair loss of my entire body.  Head/ scalp, eyebrows, eye lashes, nose hairs, mustache, some armpits, chest hair, pubic/ groin hair, arm/ legs.      1. DEPRESSION/ sadness with no head/ scalp hair, eyebrows, eyelashes.   Dramatic change of identity.  I am BALD and  my family/ friends/ patients think I have cancer b/c I have a CHEMO HEAD/ SCALP.   2. EYES/ NOSE/ THROAT irritation due to NOT having eyelashes or nose hairs.  Watery eyes/ eye sensitivity due to dust/ environament, nasal congestion and irritation due to NO nose hairs.   Time: 1st injection Dec 20, 2020 noticed some hair loss but after 2nd dose Jan 8, 2021 -> ALL HAIR GONE AFTER 1 WEEK.  HAD PRIMARY CARE PHONE CALL JAN 27, 2021 TO REPORT W/ LABS (SEE BELOW) AND EARLIEST APPT WITH DERMATOLOGIST Feb 8, 2021:  DX of alopecia areata universalis .   TREATMENT AND STILL ON TREATMENT: 1. VITAMIN D2 1250  MCG  WEEKLY, 2.  300 MG PREDNISONE PO EVERY 30 DAYS,  ALLEGRA 120 MG DAILY, MINOXIDIL 5% TWICE DAILY
Pain and couldn't lift arm. Hurt to even touch her arm, 10+ left shoulder pain scale. Severe spasms and chills lasting about 12 hours next AM on 13th pain moved to elbow; still difficult to lift; sore to bone left hand swelling, pain collarbone.
t102+ x 2 days missed 1 1/2 days of work; rt arm & glands swelled so much could not get a blouse over it; subsided p/3 days;
Had slight redness a site, along with redness which persisted for 5 days. Used ice packs prn. Never had a localized reaction for past vaccinations of any type.
Pain in my heart; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Pain in my heart) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 17-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 17-Mar-2021, the patient experienced CHEST PAIN (Pain in my heart). At the time of the report, CHEST PAIN (Pain in my heart) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication use was unknown Treatment information was unknown
hospitalized due to dehydration from COVID; she felt sick; diarrhea; loss of smell; loss of taste; felt weak; could not eat as her stomach was bothering her; soreness of her arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DEHYDRATION (hospitalized due to dehydration from COVID) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no medical history).    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced DEHYDRATION (hospitalized due to dehydration from COVID) (seriousness criterion hospitalization). On an unknown date, the patient experienced ILLNESS (she felt sick), DIARRHOEA (diarrhea), ANOSMIA (loss of smell), AGEUSIA (loss of taste), ASTHENIA (felt weak), ABDOMINAL DISCOMFORT (could not eat as her stomach was bothering her) and PAIN IN EXTREMITY (soreness of her arm). The patient was hospitalized until 07-Apr-2021 due to DEHYDRATION. On 07-Apr-2021, DEHYDRATION (hospitalized due to dehydration from COVID) had resolved. At the time of the report, ILLNESS (she felt sick), DIARRHOEA (diarrhea), ANOSMIA (loss of smell), AGEUSIA (loss of taste), ASTHENIA (felt weak), ABDOMINAL DISCOMFORT (could not eat as her stomach was bothering her) and PAIN IN EXTREMITY (soreness of her arm) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Apr-2021, COVID-19: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications were reported. Patient was hospitalized for a day and received fluids.  Company Comment: This case concerns an adult female hospitalized with serious unexpected events of covid-19 and dehydration, and nonserious unexpected illness, diarrhea, anosmia, ageusia, asthenia, abdominal discomfort, and pain in extremity.  Event latency 16 days from first dose mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: This case concerns an adult female hospitalized with serious unexpected events of covid-19 and dehydration, and nonserious unexpected illness, diarrhea, anosmia, ageusia, asthenia, abdominal discomfort, and pain in extremity.  Event latency 16 days from first dose mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Moderna COVID-19Vaccine EUA One week (8th day) after receiving first dose of Moderna COVID vaccine, I developed approx.  7cm diameter erythematous patch at the site of the vaccine administration that was very itchy. It is better on day 9, not quite as red and way less itchy.
STILL BEING TREATED IN VA FOR CHRONIC STOMACH PAINS AND LIMITED TO EATING LACTOSE, TOMATOES/SAUCE AND OTHERS. HAVE BEEN EVER SINCE ON PRILOSEC AND/OR ZANTAC. CAN'T REMEMBER EXACT DATES.
Patient received 2 vaccinations FLUVIRIN and PNEUMOVAX 23. The PNEUMOVAX 23 stung on injection. Patient complained of temperature & aches later that day & next.